News

Nicole B. Saphier, MD

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

emergency department

The perception is probably more pronounced in community hospital EDs than their academic counterparts. 

Medical malpractice gavel diagnostic error mistake stethoscope

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

TerraPower breaks ground on world's largest isotope production facility

Leaders involved in the new facility’s development estimate it will increase global Ac-225 production capacity twentyfold. 

physician burnout

Physicians who walk away from medicine before reaching their 25th year of practice tend to quit mainly due to the stress and hassles of the job.

Eden Radioisotopes believes the facility will have the capacity to produce up to 50% of the global demand for Mo-99 once completed.

U.S. FDA Sign

Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives. 

Imaging findings could explain why treatments involving aspirin and other antiplatelet drugs are not effective in some stroke patients. 

I Robot

The digital entity gave at least one end-user a phony medical-license number. Unfortunately for the chatbot, that end-user was a state investigator. 

Around the web

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.